Skip to main content
Clinical Trials/NCT06649279
NCT06649279
Completed
Not Applicable

Variations in Oxygen Reserve Index in Different Fresh Gas Flow Rate

Sakarya University1 site in 1 country64 target enrollmentJanuary 1, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Oxygen Reserve Index
Sponsor
Sakarya University
Enrollment
64
Locations
1
Primary Endpoint
Oxygen Reserve Index Value
Status
Completed
Last Updated
last year

Overview

Brief Summary

Our primary objective is to determine whether oxygen reserve index ORI can be a reliable and sensitive indicator of hypoxia and hyperoxia in low-flow anesthesia settings. Our secondary objective is to investigate the ORI changes during preoxygenation stage.

Registry
clinicaltrials.gov
Start Date
January 1, 2024
End Date
August 1, 2024
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Sakarya University
Responsible Party
Principal Investigator
Principal Investigator

Burak Kaya

Medical Doctor, Specialist

Sakarya University

Eligibility Criteria

Inclusion Criteria

  • ASA I-III patients
  • 18-75 years old
  • underwent general anesthesia
  • elective ear, nose and throat surgery, lasting longer than 60 minutes

Exclusion Criteria

  • who did not consent to participate,
  • those with finger deformities
  • unregulated diabetes mellitus, severe heart, kidney, or liver failure, sensitivities to local anesthetics or opioids, those who were morbidly obese (BMI \>40 kg/m²), and breastfeeding women.

Outcomes

Primary Outcomes

Oxygen Reserve Index Value

Time Frame: For each patient, from preoxygenation stage to the end of the general anesthesia

The Oxygen Reserve Index (ORI) is a real-time monitoring measure that captures the oxygen reserve status in the moderate hyperoxic range (PaO2 approximately 100 to 200 mmHg). ORI provides early warning of potential oxygenation disturbances before any changes occur in SpO2 and indicates the response to oxygen therapy. ORI ranges from 1 (high reserve) to 0 (no reserve) and measures changes in mixed venous oxygen saturation (SvO2) optically after arterial oxygen saturation reaches 100%.

Study Sites (1)

Loading locations...

Similar Trials